Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000150:complications; D000391:Air Microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000898:Antibiosis; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000985:Antisepsis; D004032:Diet; D004780:Environment, Controlled; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D017053:Infection Control; D007938:Leukemia / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000628:therapy; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010357:Patient Isolators; D011379:Prognosis; D011446:Prospective Studies; D012075:Remission, Spontaneous
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents